Brief: Oncolytics Biotech Announces Underwritten Public Offering
13/08/2019 23:23
Aug 13 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH INC - INTENDS TO OFFER TO SELL COMMON
SHARES
AND WARRANTS TO PURCHASE COMMON SHARES IN AN UNDERWRITTEN PUBLIC
OFFERING
* ONCOLYTICS BIOTECH - INTENDS TO USE NET PROCEEDS OF
OFFERING FOR
RESEARCH AND DEVELOPMENT ACTIVITIES AND WORKING CAPITAL PURPOSES
Source text: (ID: https://bit.ly/2N0NvEr)
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer